Showing results (401-410 of 609) with videos related to
Sort By:
Pageof 61
European Journal of Medicinal Chemistry|February 9, 2016
Modification of the length and structure of the linker of N(6)-benzyladenosine modulates its selective antiviral activity against enterovirus 71Mikhail S Drenichev, Vladimir E Oslovsky, Liang Sun, et al.Biochemical and Biophysical Research Communications|December 3, 2014
A thiazepino[4,5-a]benzimidazole derivative hampers the RNA replication of Eurasian serotypes of foot-and-mouth disease virusDavid J Lefebvre, Annebel R De Vleeschauwer, Nesya Goris, et al.Journal of Medicinal Chemistry|August 29, 2018
Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus ReplicationLaurène Da Costa, Els Scheers, Antonio Coluccia, et al.European Journal of Medicinal Chemistry|May 5, 2022
Organotropic dendrons with high potency as HIV-1, HIV-2 and EV-A71 cell entry inhibitorsOlaia Martí-Marí, Belén Martínez-Gualda, Irene Fernández-Barahona, et al.Antimicrobial Agents and Chemotherapy|May 21, 2014
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell cultureAdriaan H de Wilde, Dirk Jochmans, Clara C Posthuma, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 8, 2007
Improved crystallization of the coxsackievirus B3 RNA-dependent RNA polymeraseIlham Jabafi, Barbara Selisko, Bruno Coutard, et al.Plos Pathogens|March 11, 2026
A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal modelsZhengyu Ye, Wenhao Dai, Shaolin Zhang, et al.Journal of Medicinal Chemistry|June 6, 2017
A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus ReplicationJinwoo Kim, Yu Kyoung Jung, Chonsaeng Kim, et al.Antiviral Research|June 29, 2021
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agentsThuc Nguyen Dan Do, Kim Donckers, Laura Vangeel, et al.Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.Pageof 61